PGIM Short Duration High Yield ETF (PSH)

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon’s services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Since its founding in 1946, Estee Lauder has become a leading global manufacturer and marketer of prestige skin care (nearly half of sales), makeup (28%), fragrance (19%), and haircare products (4%). Beyond its namesake brand, the firm's portfolio of offerings includes Clinique, M.A.C., La Mer, Jo Malone London, and Tom Ford, among others. The US and China each account for about one-quarter of its consolidated sales. The firm sells its products through physical and e-commerce platforms at company-owned outlets alongside department stores, specialty retailers, and salons globally.

The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.